- Home
- ZYXI vs BNTC Comparison
ZYXI vs BNTC Comparison
Compare ZYXI & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- BNTC
- Stock Information
- Founded
- ZYXI 1996
- BNTC 1995
- Country
- ZYXI United States
- BNTC United States
- Employees
- ZYXI N/A
- BNTC N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- BNTC Health Care
- Exchange
- ZYXI Nasdaq
- BNTC Nasdaq
- Market Cap
- ZYXI 261.5M
- BNTC 255.9M
- IPO Year
- ZYXI N/A
- BNTC N/A
- Fundamental
- Price
- ZYXI $7.19
- BNTC $11.30
- Analyst Decision
- ZYXI Strong Buy
- BNTC Strong Buy
- Analyst Count
- ZYXI 2
- BNTC 7
- Target Price
- ZYXI $14.00
- BNTC $24.43
- AVG Volume (30 Days)
- ZYXI 76.5K
- BNTC 24.1K
- Earning Date
- ZYXI 03-07-2025
- BNTC 02-14-2025
- Dividend Yield
- ZYXI N/A
- BNTC N/A
- EPS Growth
- ZYXI N/A
- BNTC N/A
- EPS
- ZYXI 0.15
- BNTC N/A
- Revenue
- ZYXI $193,665,000.00
- BNTC N/A
- Revenue This Year
- ZYXI $10.70
- BNTC N/A
- Revenue Next Year
- ZYXI $19.78
- BNTC N/A
- P/E Ratio
- ZYXI $48.68
- BNTC N/A
- Revenue Growth
- ZYXI 4.21
- BNTC N/A
- 52 Week Low
- ZYXI $7.12
- BNTC $3.66
- 52 Week High
- ZYXI $13.77
- BNTC $13.29
- Technical
- Relative Strength Index (RSI)
- ZYXI 34.08
- BNTC 52.38
- Support Level
- ZYXI $7.27
- BNTC $10.92
- Resistance Level
- ZYXI $7.70
- BNTC $11.65
- Average True Range (ATR)
- ZYXI 0.28
- BNTC 0.70
- MACD
- ZYXI -0.04
- BNTC 0.06
- Stochastic Oscillator
- ZYXI 6.93
- BNTC 61.54
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.